Clinical Trials in Detroit

Showing 9361-9380 of 14,997 trials

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

NCT01925417

This study will assess the safety of a new biologic drug, RBX2660 (microbiota suspension) as a treatment for recurrent Clostridium difficile-associated diarrhea (CDAD), which is the primary symptom of recurrent Clostridium difficile infection. All eligible subjects will receive RBX2660.

Recurrent Clostridium Difficile Infection

Rebiotix Inc.34 participantsStarted Aug 2013

Phoenix, Arizona, United States • Denver, Colorado, United States • Jacksonville, Florida, United States +10 more locations

COMPLETEDPhase 1< 1 mile

Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease

NCT01522547

The purpose of the study is to determine the maximum tolerated dose, safety and effect on induction of fetal hemoglobin of pomalidomide in patients with Sickle Cell Disease.

Anemia, Sickle Cell

Celgene12 participantsStarted Aug 2007

Detroit, Michigan, United States

COMPLETEDNA< 1 mile

SPRINT - Randomized Trial of Tibial Fracture Fixation

NCT00038129

The purpose of this study is to determine if there is a difference in the rate of healing of a tibia fracture treated with an intramedullary nail based on whether or not the bone was reamed prior to nail insertion.

Tibial Fracture

University of Minnesota1,200 participantsStarted May 2002

San Francisco, California, United States • Jacksonville, Florida, United States • Evansville, Indiana, United States +13 more locations

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease

SPRINT - Randomized Trial of Tibial Fracture Fixation

Find Trials by Condition in Detroit

Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Study of Debio 1450 for Bacterial Skin Infections

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

POSITIVE Stroke Clinical Trial

Study in Subjects With Moderate Atopic Dermatitis

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Lapatinib and Trastuzumab With or Without Endocrine Therapy

Estimating Average Vitamin A Requirements in Indonesian and American Women

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2